Download Job Description

Job title:
Specialty Doctor in Oncology
Division:
Cancer Division
Board/corporate function:
Surgery & Cancer
Salary band:
Specialty Doctor Grade
Responsible to:
Clinical Lead Chemotherapy
Clinical Lead Acute Oncology Service
Accountable to:
Divisional Clinical Director of Cancer Services
Hours per week:
40
Location:
UCH/UCH Macmillan Cancer Centre
University College London Hospitals NHS Foundation Trust
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most
complex NHS trusts in the UK, serving a large and diverse population.
We provide academically-led acute and specialist services, to people from the local
area, from throughout the United Kingdom and overseas.
Our vision is to deliver top-quality patient care, excellent education and world-class
research. We provide first-class acute and specialist services across eight sites:








University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)
National Hospital for Neurology and Neurosurgery
Royal National Throat, Nose and Ear Hospital
Eastman Dental Hospital
Royal London Hospital for Integrated Medicine
University College Hospital Macmillan Cancer Centre
The Hospital for Tropical Diseases
University College Hospitals at Westmoreland Street
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH
specialises in women’s health and the treatment of cancer, infection, neurological,
gastrointestinal and oral disease. It has world class support services including critical
care, imaging, nuclear medicine and pathology.
The appointment
An exciting opportunity has arisen for a full-time NHS appointment (10 PAs) at
University College London Hospitals (UCLH) to work and to develop new pathways of
care for patients living with cancer in the emergency, acute assessment, elective day
care, and clinic settings.
In addition to extensive clinical experience within the inpatient and outpatient settings,
the postholder will be supported in leading service developments within this large
tertiary cancer centre. The aim of this post is to help develop the transfer of care from
the emergency department and inpatient setting to the day care environment within the
new state-of-the-art UCH Macmillan Cancer Centre. In addition, the postholder will
have the opportunity to review and audit the evolving service and be involved in
research projects.
There are currently 39 beds for oncology inpatients receiving care for a range of
malignancies. Elective admissions are for delivery of chemotherapy, radiotherapy
including radioisotope treatment, symptom care and management of complications of
cancer treatment. The post holder will work closely with core medical trainees and
oncology specialist registrars to ensure effective delivery of care from admission
through to discharge and the day care/clinic environment as required. The post holders
will fulfil a pivotal liaison role between other departments such as accident and
emergency and the acute medical admissions and will be expected to liaise with
consultant oncologists as needed. The post holders will be expected to take an active
role in education, training and audit in relation to the ward and day care service of
junior doctors, nurses, CNS’s and other allied health care professionals.
This post would be suitable for a senior trainee who intends to pursue an academic or
NHS oncology career. The postholder will be responsible to the Lead Clinicians for
Chemotherapy and Acute Oncology at UCH. Eligibility for full GMC Registration is
required. Possession of MRCP or equivalent is desirable. Specialist training in clinical
or medical oncology with experience in delivery of chemotherapy is desirable. The
clinical sessions will be based in the cancer centre day unit, clinics and the inpatient
wards/emergency department, but the postholder may need to see some patients at
other locations within the Trust.
University College Hospital (UCH) is a new state-of-the-art hospital in central London
(http://www.uclh.nhs.uk/), with access to all types of cancer therapy and imaging,
including MRI-PET and functional imaging, and molecular pathological services. The
newly built UCH Macmillan Cancer Centre provides a unique environment for the
investigation and treatment of cancer patients. In-patient and radiotherapy facilities are
located in the main UCH building close by. UCL is one of the U.K.’s premier research
and teaching Universities (www.ucl.ac.uk) and has one of the largest Biomedical
Faculties in Europe. UCL is both a Cancer Research UK Centre and an Experimental
Cancer Medicine Centre providing key infrastructure for cancer research. The
UCLH/UCL partnership has been awarded Comprehensive Biomedical Research
Centre status by the National Institute for Health Research and Cancer is a major
theme. See below for information on Institutional profiles and Cancer Research at
UCH and UCL.
The full-time post is funded 100% by the UCH Cancer Division and is available for 1
year in the first instance.
Further Information & Visits to the Hospital
General enquiries, about the job or for an informal discussion about this post should be
directed to Dr Martin Forster ([email protected]) or Dr Kai-Keen Shiu
([email protected])
Main Duties & Responsibilities
The two post holders will join the existing third post holder, working on a rotational
basis to share and internally cross cover the following duties and responsibilities;
Clinical

Provide assessment, triage and treatment plans for unwell oncology patients
providing integrated and cohesive outpatient and inpatient levels of care in
conjunction with existing oncology trainees and consultants.

Assess and instigate initial management of acute admissions to UCH to the
Emergency Department or Cancer Centre (either patients with known
malignancy or with a suspected cancer diagnosis, patients with carcinoma of
uncertain primary) supporting the CMTs, Specialist Registrars, or referrers as
part of the Acute Oncology (AOS) and CUP Service led by Dr Shiu.

Carry out a daily ward round with the Acute Oncology Consultant of the week,
Acute Oncology SHO and Acute Oncology CNS, for assessment and
management of oncology patients admitted within 24 hours to the trust or
referred to the AOS with a suspected cancer diagnosis.

Provide medical care for patients undergoing treatment in the UCH Cancer
Centre chemotherapy and day assessment unit.

Undertake one out-patient tumour specific oncology clinic per week

Attend the relevant tumour specific MDM each week.

Work together with the SpRs in medical and clinical oncology to support the
junior medical staff on the oncology wards for existing unwell patients.

Maintain ALS skills

Be aware of, and comply with, patient confidentiality and freedom of information
act

Be aware of ethical issues which arise in end-of-life care

Any other duties which may be reasonably requested by the Clinical Lead for
Chemotherapy or the Divisional Clinical Director
Service Development

Work with the Clinical Leads and Divisional Clinical Director and management
to develop an oncology emergency assessment and treatment service on the
Day Care Unit in the UCH Macmillan Cancer Centre

Take responsibility for researching and analysing best practice

Lead on the development of agreed conditions and procedures to be serviced in
the triage and treatment service.

Develop and implement protocols and pathways division wide

Liaise closely with Emergency Services Division to develop a seamless service
for oncology inpatients and outpatients.

Work with junior medical staff to ensure doctors’ skills are enhanced by the
triage and treatment service.
Clinical Governance & Audit

Attend and participate in educational and governance activities – including day
unit inpatient MDTs and departmental meetings

Undertake Clinical Audit Projects related to Cancer Services

Maintain high standards of clinical note keeping

Contribute towards developing, monitoring and reviewing the service including
preparing reports as required
Audit triage and treatment service


Post holders will be fully supported in presenting practice changing audits to the
Cancer Division, Trust and external meetings by their Clinical Supervisors Dr
Forster and Dr Shiu.

Coordinate the SHO rotas and leave.
Research & Teaching

Maintain GCP updates and skills.

Develop and initiate research projects (with the guidance of other faculty)

Participate in the late phase clinical trials programme taking responsibility as
appropriate in the clinic

Undertake continued professional development and attend national and
international conferences to keep abreast of field

Critically analyze clinical research literature relevant to position and have a
basic knowledge on clinical databases and relevant statistical approaches

Coordinate the SHO local departmental induction programme.

Oversee the SHO weekly SpR-led teaching programme.

Conduct lectures, seminars or tutorials for junior staff and medical students as
part of their ongoing training; post holders will be encouraged to attending
courses both within and external to the Trust to attain formal teaching
qualifications
Further Information re UCL
The Trust’s mission statement is:
“UCLH is committed to delivering top quality patient care, excellent education
and world class research”.
To achieve this mission statement, the Trust works closely with UCL.
UCL is one of the UK’s premier universities and is ranked in the world’s top 10. It is a
world-class research and teaching institution based in London whose staff and former
students have included 20 Nobel Prize winners.
UCL is one of the largest and most prestigious aggregations of academics in
biomedical, life and population health sciences and has a total of 54 Academic
Departments and Institutes including:








Wolfson Institute for Biomedical Research
Division of Surgical & Interventional Sciences
Cancer Institute (Director – Professor Chris Boshoff)
Eastman Dental Institute
Institute of Hepatology
Division of Medicine
Division of Medical Education
Division of Infection & Immunity
UCL aims to create in the heart of London, a world-class environment for basic and
clinical cancer research. UCL and UCLH are significantly investing in cancer treatment
and research infrastructure:




£50 million new Cancer Institute opened in 2007
Early phase cancer trials in the UCL/UCLH Clinical Research facility opened in 2009
£100 million UCH Macmillan Cancer Centre opened in 2012
Planning for the proton beam treatment centre to open in 2016
The Trust has an arrangement with the Medical School to provide clinical teaching for
the MBBS undergraduate programme, and is funded by the NHS to do this, and
recognised by the University of London for this teaching programme.
UCL and UCLH have recently come together with other NHS partners (Royal Free
Hospital NHS Trust, Great Ormond Street Hospital NHS Trust, Moorfields Hospital
NHS Trust) to form UCL and Partners. This partnership allows the university and NHS
organisations to work together to achieve their joint ambition to be an internationally
recognised academic health science centre. The UCLH commitment in the mission
statement – to carry out clinical services, teaching, and research in a truly collaborative
way – is central to everything that the Trust does.
Services Provided by the Trust
The services provided by UCLH are managed through three Clinical Boards –
Medicine, led by Medical Director Dr Charles House; Surgery and Cancer, led by
Medical Director Professor Geoff Bellingan and Specialist Hospitals, led by Medical
Director Dr Gill Gaskin. The Corporate Medical Director, Professor Tony Mundy, has
responsibility for corporate clinical governance, research and development, and
education functions.
The Medicine Board provides services largely based in the UCH Tower, including high
quality accident and emergency and general medical and general surgical services to
people who live, work and visit North Central London. These services are managed
through 6 clinical divisions, each headed by a Divisional Clinical Director and
Divisional Manager – emergency services, medical specialties, infection, critical care,
pathology and clinical support.
The Specialist Hospitals Board manages services both at UCH and at other sites, also
managed through 6 divisions, each with a Divisional Clinical Director and Divisional
Manager: Queens Square (National Hospital for Neurology and Neurosurgery and
Royal London Hospital for Integrated Medicine), Women’s Health (Elizabeth Garrett
Anderson wing of University College Hospital), Eastman Dental Hospital, Child Health
and the Royal Ear, Nose and Throat Hospital.
The Surgery and Cancer Board provides services based in the UCH Tower, UCH at
Westmoreland Street and the UCH Macmillan Cancer Centre, with 5 divisions, each
with a Divisional Clinical Director and Divisional Manager: Cancer, Surgical specialties,
Gastrointestinal services, Imaging and Theatres and Anesthesia.
The Trust’s clinical services are supported by effective investment in information and
communications technology, and mature relationships with our ICT partner, CGI. The
systems provide high levels of functionality in the electronic patient record, which is
used by all staff groups. Further investment is planned over the coming years.
Further information about the Trust, its strategic direction and hospitals can be found
on the UCLH Website @ www.uclh.nhs.uk
The Cancer Division
The Cancer Services Division is managed jointly by Dr Kirit Ardeshna (Divisional
Clinical Director) and Mr Nick Kirby (Divisional Manager). The division is responsible
for:
 Developing and implementing the Cancer Strategy for UCLH, as well as
implementing cancer standards and cancer waiting times across the Trust
 Clinical haematology
 Oncology



Chemotherapy
Radiotherapy
UCH Macmillan Cancer Centre
Working closely with the UCL Cancer Institute, the division is implementing a
programme of change and investment to make UCL and UCLH one of the top cancer
centres in Europe. The UCLH Board of Directors supported this strategy with
agreement to invest £100million in a new cancer centre, which has been built directly
opposite the Cancer Institute in Huntley Street. This strategic programme of work will
ensure that clinical research, clinical outcomes, pathways and waiting times,
partnerships, productivity and profitability and the patient environment and experience
will all be developed to match the aspirations of the Trust and UCL for cancer
services. UCLH has been designated as one of the two proton therapy sites to be built
in the UK, this is due to open to patients in 2019. The development of effective clinical
partnerships and cancer patient pathways with other Trusts within the new provider
network, London Cancer (www.londoncancer.org), is a crucial component of this
Cancer strategy.
Clinical haematology (Lead clinician Dr Kirsty Thomson) has 71 in-patient beds, all
single rooms with ensuite facilities on levels 13 14 and 16 of the new University
College Hospital. Outpatient and daycare facilities are shared with the oncology
directorate. There are active clinical and research programmes in leukaemia,
lymphoma, myeloma, transplant, clotting and TTP, red cell and anti-coagulation. The
directorate works closely with laboratory haematology services, which are managed as
part of the clinical support division. There is a cellular therapy unit provides accredited
facilities to support the department’s ambitious programme in stem cell harvests, gene
therapy and immunotherapy. In December 2015 the malignant haematology service
from the Royal Free Hospital was integrated with and transferred to UCH. This is now
one of the largest in Europe Haematology services in Europe.
Oncology (Lead clinician Dr Naomi Fersht) has 39 beds on levels 10, 13 and 14 of
University College Hospital, shares outpatient and daycases with clinical haematology,
and employs medical and clinical oncologists working in cancer MDTs across the
whole of UCLH. The team is supported by 12 clinical oncology registrars, 7 medical
oncology registrars and 3 oncology speciality doctors.
The radiotherapy directorate (Lead Clinician Dr Yen Ching Chang) is located on level 2 of University College Hospital, undertaking 2000 new courses of treatment per
year. Equipment includes 5 Varian linear accelerators, all with multileaf collimators
and portal vision and some with respiratory gating and onboard imaging. There is a
high dose rate microselectron unit, and planning equipment (CT simulator as well as
access to CT PET equipped to match the facilities on the linear accelerators.) The
department offers a variety of specialised treatment, including CT-based TBI,
ultrasound-guided and CT-planned HDR brachytherapy, high precision conformal
radiotherapy utilising MR/PET/CT fusion, IMRT and stereotactic radiotherapy.
The Division is also supported by Clinical Lead posts in Chemotherapy Services (Dr
Martin Forster), and the Teenage and Young Adults Cancer Service (Dr Rachael
Hough)
Consultant Medical Oncologists:
Prof JA Ledermann MD FRCP (Hon Consultant), Prof JS Whelan MD FRCP
(Consultant ), Prof S Ming Lee PhD FRCP (Consultant), Prof R Stein PhD FRCP
(Consultant), Prof J Bridgewater PhD FRCP (Hon Consultant – joint with the North
Middlesex Hospital). Prof D Hochhauser PhD FRCP (Hon Consultant), Dr Sandra
Strauss PhD, MRCP (Senior Lecturer and Hon Consultant), Dr Martin Forster, MRCP
(Senior Lecturer and Hon Consultant), Dr Rebecca Kristeleit PhD, MRCP (Senior
Lecturer and Hon Consultant), Prof Tim Meyer PhD FRCP (joint with RFH), Prof
Charlie Swanton PhD FRCP FMedSci (Hon Consultant), Dr. Paul Mulholland PhD,
MRCP (joint with Mount Vernon), Dr Palma Dileo MD, Prof. Richard Kaplan MD (Hon
Consultant), Prof Tom Powles MBBS, MD, MRCP (Hon Consultant), Dr Tobi Arkenau
MD PhD (Hon Consultant) Dr Tanya Ahmed MRCP (joint with Royal Free Barnet), Dr
Ursula McGovern PhD FRCP (joint with Royal Free Barnet and Hon Senior Lecturer),
Dr Fharat Raja MRCP (joint with North Midddlesex), Dr Mark Linch PhD MRCP
(Consultant & Hon Senior Lecturer), Dr Michelle Lockley Phd FRCP (Reader QMUL
and Honorary Consultant) Dr Kai-Keen Shiu PhD MRCP, Dr Rebecca Roylance PhD
FRCP.
Consultant Clinical Oncologists:
Dr Dawn Carnell BSc MRCP FRCR, Dr Yen Ching Chang MRCP FRCR (with Great
Ormond Street), Dr Mark Gaze MD FRCP FRCP(E) FRCR (with Great Ormond
Street), Dr Anita Mitra, MD MRCP FRCR, Prof Ricky Sharma PhD FRCP (Hon
Consultant), Prof Heather Payne MRCP FRCR, Dr Mary McCormack PhD FRCR, Dr
Beatrice Seddon PhD MRCP FRCR, Dr Ruheena Mendes MD FRCP FRCR, Dr Naomi
Fersht PhD MRCP FRCR, Dr Elena Wilson MB BS MRCP FRCR, Dr Tom Richards
MRCP FRCR
Other staff: Specialty doctors for oncology in patient services and cancer centre, 12
Clinical Oncology Specialist Registrars, 4 Medical Oncology Specialist Registrars, 3
Clinical Fellows and 7 Core Medical trainees or equivalent, shared between medical
and clinical oncology.
Other
The job description is not intended to be exhaustive and it is likely that duties may be
altered from time to time in the light of changing circumstances and after consultation
with the post holder.
You will be expected to actively participate in annual appraisals and set objectives in
conjunction with your manager. Performance will be monitored against set objectives.
Our Vision and Values
The Trust is committed to delivering top quality patient care, excellent education and
world-class research.
We deliver our vision through values to describe how we serve patients, their families
and how we are with colleagues in the Trust and beyond.
We put your safety and wellbeing above everything
Deliver the best
outcomes
Keep people safe
Reassuringly
professional
Take personal
responsibility
We offer you the kindness we would want for a loved one
Respect
individuals
Friendly and
courteous
Attentive and
helpful
Protect your
dignity
Work in
partnership
Respect
everyone’s time
Develop through
learning
Innovate and
research
We achieve through teamwork
Listen and hear
Explain and involve
We strive to keep improving
Courage to give and
receive feedback
Efficient and
simplified
UCL Hospitals NHS Trust has adopted an Equal Opportunities Policy and specific
regard should be taken of its content in relation to the treatment of employees or
potential employees.
This job description is not intended to be exhaustive and it is likely that duties may be
altered from time to time in the light of changing circumstances and after consultation
with the post holder.
DATA PROTECTION:
If required to do so, employees must obtain, process and/or use information held in a
computer or word processor in a fair and lawful way; to hold data only for specific
registered purposes and not use or disclose it in any way incompatible with such
purpose. They should disclose data only to authorised organisations as instructed.
CONFIDENTIALITY:
All employees are required to exercise discretion and maintain confidentiality at all
times.
EQUAL OPPORTUNITIES:
It is the aim of UCL Hospitals to ensure that no job applicant or employee receives less
favourable treatment on the grounds of gender, sexuality, race, colour, religion, marital
status, learning difficulties, mental health history, disability, age, nationality or ethnic or
national origins or is not placed at a disadvantage by conditions or requirements which
cannot be shown to be justifiable. To this end, there is an Equal Opportunities Policy
and the post holder must at all times carry out his/her duties in accordance with this
policy.
HEALTH & SAFETY:
Employees must be aware of the responsibilities placed on them under the Health &
Safety at Work Act (1974), and to ensure that agreed safety procedures are carried out
to maintain a safe environment for employees, patients and visitors. All employees
must comply with Trust policies for personal and patient safety and for prevention of
healthcare-associated infection (HCAI); this includes a requirement for rigorous and
consistent compliance with Trust policies for hand hygiene, use of personal protective
equipment and safe disposal of sharps
NO SMOKING:
The Trust operates a smoke free policy and no smoking is allowed on Trust property.
CUSTOMER AWARENESS:
UCL Hospitals expects its employees to communicate with colleagues, patients and
visitors in a polite and courteous manner at all times.
PATIENTS’ CHARTER:
We are committed to meeting the rights and standards required by the Patients’
Charter. We expect our staff to be aware of these rights and standards and to be fully
involved and co-operative in meeting them.
Person Specification
Post: Specialty Doctor in Oncology
REQUIREMENTS
MET
HOW TESTED?
APPLICATION TEST INTERVIEW
E/D*
A
T
I
MBBS or equivalent
E

MRCP or equivalent
D

Full registration with the GMC
E

Minimum 4 yrs full-time
postgraduate training in medicine
or part-time equivalent since first
obtaining registration
E


Management of all aspects of care
of patients with complex cancers
undergoing intensive treatment as
part of a multi-disciplinary team
E


Experience of clinical teaching and
supervision of junior staff
E


Qualifications
Experience
Skills, Ability & Knowledge
Candidates Name: …………...
Job Ref: UCH/
R
Not Met
EVIDENCE TO SUPPORT
ASSESSMENT
REQUIREMENTS
E/D*
A
E

E


Accountability; ability to take
responsibility, lead, make
decisions and exert appropriate
authority.
E


Interpersonal Skills; ability to see
patients as people, ability to
empathise and work co-operatively
with others.
E


Research in related field
D


Ability to organise, prioritise own
workload and be able to work own
initiative
E


Demonstrate Ability to undertake
E


Attendance at emergency and
resuscitation courses e.g. ALS
Communication; ability to
communicate with clarity and
intelligently in written and spoken
English; ability to build rapport,
listen, persuade/ negotiate.
MET
HOW TESTED?
APPLICATION TEST INTERVIEW
T
I
Audit, Management & IT
R
Not Met
EVIDENCE TO SUPPORT
ASSESSMENT
REQUIREMENTS
MET
HOW TESTED?
APPLICATION TEST INTERVIEW
E/D*
A
Understanding of Equal
Opportunities
E

Evidence of publications in peerreviewed journals
D

T
I
Not Met
R
Clinical Audit/Governance and
lead new projects
Other Requirements
* Essential/Desirable
Drawn up by:
A - Application Form
T - Test
Dr Kai-Keen Shiu and Dr Martin Forster
I - Interview
Date: June 2015
R - References
EVIDENCE TO SUPPORT
ASSESSMENT